Hybrigenics PE 2024

Ko dara Hybrigenics?

Hybrigenics SA is a French company that was founded in 1997 to develop innovative technologies for the discovery and development of new drugs. The company specializes in the identification of proteins responsible for the development of cancer and other diseases, as well as the development of therapies for these diseases. It is headquartered in Paris and has branches in the United States and Japan. Hybrigenics has become a leading provider of protein research technologies since its founding, employing approximately 50 employees including scientists, engineers, and technicians. The company's business model is based on developing innovative technologies for drug discovery and development. It conducts research and development in the field of protein research, particularly protein interaction analysis. The company aims to better understand the mechanism of action of proteins involved in disease development in order to develop targeted therapies. Hybrigenics collaborates closely with its customers to develop tailored solutions for their specific research needs. It provides a range of products and services including proteomic services, screening tools, data analysis software, and platform technologies. The company is divided into different divisions, including proteomic services, screening tools, data analysis software, and platform technologies. Some of the key divisions include proteomic services, which offer customers proteomic services based on decades of experience in protein research and analysis. These services allow customers to identify new proteins involved in specific diseases and also provide protein interaction analysis services to better understand the mechanism of action of disease proteins. Hybrigenics offers screening tools that allow customers to quickly and easily investigate and compare different proteins. These tools are particularly useful for identifying proteins that can serve as indicators for specific diseases. The company also offers data analysis software that enables customers to quickly and accurately evaluate the results of their protein research. This software uses algorithms and artificial intelligence to analyze data and identify patterns. Hybrigenics has also developed a range of platform technologies to help customers optimize their protein research. These technologies include the yeast two-hybrid assay, which can be used to study protein interactions, as well as various technologies for protein expression and purification. Hybrigenics offers a variety of products tailored to its different divisions. Some of the key products include the PIII-Toolbox, a comprehensive platform technology for protein research that allows for fast and efficient identification of protein-protein interactions, HybriScreen Plus, a screening tool that helps customers quickly and easily investigate and compare different proteins, and the yeast two-hybrid assay, a platform technology for studying protein interactions to better understand the mechanism of action of disease proteins. Hybrigenics ist eines der beliebtesten Unternehmen auf Eulerpool.com.